Trademark: 90076369
Word
MITYTRAV
Status
Dead
Status Code
606
Status Date
Monday, July 3, 2023
Serial Number
90076369
Mark Type
4000
Filing Date
Monday, July 27, 2020
Published for Opposition
Tuesday, April 6, 2021
Abandoned Date
Monday, July 3, 2023

Trademark Owner History
Bristol-Myers Squibb Company - Owner At Publication

Classifications
5 Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; Pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; Pharmaceutical preparations for human use that modulate the immune system; Pharmaceutical and biological preparations for human use for immunotherapy, namely T Cell therapy; Pharmaceutical preparations for human use, namely, stem cells for medical or clinical use
The wording "MITYTRAV" has no meaning in a foreign language.

Trademark Events
Jul 3, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Jul 3, 2023
Abandonment - No Use Statement Filed
Nov 30, 2022
Notice Of Approval Of Extension Request E-Mailed
Nov 28, 2022
Sou Extension 3 Granted
Nov 28, 2022
Sou Extension 3 Filed
Nov 28, 2022
Teas Extension Received
May 26, 2022
Notice Of Approval Of Extension Request E-Mailed
May 24, 2022
Sou Extension 2 Granted
May 24, 2022
Sou Extension 2 Filed
May 24, 2022
Teas Extension Received
Dec 3, 2021
Notice Of Approval Of Extension Request E-Mailed
Dec 1, 2021
Sou Extension 1 Granted
Dec 1, 2021
Sou Extension 1 Filed
Dec 1, 2021
Teas Extension Received
Jun 1, 2021
Noa E-Mailed - Sou Required From Applicant
Apr 6, 2021
Official Gazette Publication Confirmation E-Mailed
Apr 6, 2021
Published For Opposition
Mar 17, 2021
Notification Of Notice Of Publication E-Mailed
Mar 1, 2021
Approved For Pub - Principal Register
Mar 1, 2021
Teas/Email Correspondence Entered
Feb 26, 2021
Correspondence Received In Law Office
Feb 26, 2021
Teas Response To Office Action Received
Sep 1, 2020
Notification Of Non-Final Action E-Mailed
Sep 1, 2020
Non-Final Action E-Mailed
Sep 1, 2020
Non-Final Action Written
Sep 1, 2020
Assigned To Examiner
Aug 26, 2020
New Application Office Supplied Data Entered
Jul 30, 2020
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24